LYVE1 and colorectal carcinoma: As an illustration, LYVE1+RTMs are linked to the suppression of inflammation and fibrosis in colorectal cancer (CRC) [41], while SPP1+TAMs are linked to tumor angiogenesis in CRC [41], and FOLR2+TAMs support onco-fetal reprogramming of TME in HCC [43].